Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study
Authors:
- Toyonori TsuzukiTTToyonori Tsuzuki
- Chisato OheCOChisato Ohe
- Takahiro OsawaTOTakahiro Osawa
- Toshiaki TanakaTTToshiaki Tanaka
- Satoshi AnaiSASatoshi Anai
- Go KimuraGo Kimura
- Kazutoshi YamanaKYKazutoshi Yamana
- Shingo HatakeyamaSHShingo Hatakeyama
- Takuya YoshimotoTYTakuya Yoshimoto
- Yuki NakagawaYNYuki Nakagawa
- Tamaki FukuyamaTFTamaki Fukuyama
Open Access
- 20 September 2022
- Vol. 55 (1) , 31-39
Abstract
No abstract availableKeywords
Funding Information
- F. Hoffmann-La Roche Ltd
- Chugai Pharmaceutical
This publication has 32 references indexed in Scilit:
- Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiationCancer, 2017
- Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2017
- HYPE or HOPE: the prognostic value of infiltrating immune cells in cancerBritish Journal of Cancer, 2017
- Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell CarcinomaCancer Research, 2017
- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison ProjectJournal of Thoracic Oncology, 2017
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint InhibitionClinical Cancer Research, 2016
- PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosisDiagnostic Pathology, 2015
- Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell CancerClinical Cancer Research, 2015
- Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging SystemJournal of Clinical Oncology, 2001
- A Confidence Interval for the Median Survival Time1982